Trial | NCT00399451  Report issue

Title

Polidocanol Sclerotherapy of Pharynges for Obstructive Sleep Apnea (OSA) and Snoring Subjects(SS)
Preliminary Study on Submucous Sclerosis of Pharynges With 1% Polidocanol to Treat Obstructive Sleep Apnea (OSA) & Snoring Subjects (SS)

  • Phase

    Phase 1/Phase 2

  • Study Type

    Interventional

  • Status

    Unknown status

  • Intervention/Treatment

    polidocanol ...

  • Study Participants

    30
The aim of this prospective study is to evaluate the results of polidocanol sclerotherapy of pharynx for OSAS & SS,to reduce pharyngeal compliance.
Polidocanol submucous sclerosis in the part of pharynges with 1% polidocanol injection.The injection should be in the retropharyngeal submucosa and lateral pharyngeal bands and lateral pharyngeal submucosa and in front submucosa of soft palate.The injection is multi-point,and each point injection is 0.3~0.5ml;the total quantity/each time is not more than 5ml.Every patient have to be treated about 1~2 time.
Study Started
Dec 31
2006
Study Completion
Jun 30
2009
Last Update
Nov 22
2006
Estimate

Drug Polidocanol Sclerotherapy

Criteria 

Inclusion Criteria:

OSAS & SS which palatopharyngeal collapse.

Exclusion Criteria:

obstructive sleep apnea syndrome (osas) & snoring subjects (ss),which anatomic narrow result in.
No Results Posted